Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-02

Clinical Trial Update: Nalbuphine Versus Morphine for Mucositis Pain in Pediatric Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing nalbuphine to morphine for mucositis pain in pediatric cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (morphine)
  • Nalbuphine (nalbuphine)

Snippet

Sponsor: Children's Cancer Hospital Egypt 57357 | Conditions: Acute Myeloid Leukemia, Stem Cell Leukemia | Phase 3 | Status: COMPLETED